相似文献
1
Phage therapy: concept to cure.噬菌体疗法：从概念到治愈。
Front Microbiol. 2012 Jul 19;3:238. doi: 10.3389/fmicb.2012.00238. eCollection 2012.
2
Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.噬菌体疗法：概述及意大利传染病与热带病学会的立场
Infez Med. 2020 Sep 1;28(3):322-331.
3
The forgotten tale of Brazilian phage therapy.巴西噬菌体疗法被遗忘的故事。
Lancet Infect Dis. 2020 May;20(5):e90-e101. doi: 10.1016/S1473-3099(20)30060-8. Epub 2020 Mar 23.
4
Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?噬菌体 - 抗生素联合治疗：抗生素对噬菌体治疗药效学的拮抗作用？
Antibiotics (Basel). 2019 Oct 11;8(4):182. doi: 10.3390/antibiotics8040182.
5
Phage therapy dosing: The problem(s) with multiplicity of infection (MOI).噬菌体疗法给药：感染复数（MOI）的问题。
Bacteriophage. 2016 Aug 11;6(3):e1220348. doi: 10.1080/21597081.2016.1220348. eCollection 2016 Jul-Sep.
6
Implementation of a targeted mastitis therapy concept using an on-farm rapid test: antimicrobial consumption, cure rates and compliance.应用农场快速检测实施靶向乳腺炎治疗方案：抗菌药物使用、治愈率和合规性。
Vet Rec. 2020 Nov 14;187(10):401. doi: 10.1136/vr.105674. Epub 2020 Oct 6.
7
[A short history of phage therapy].[噬菌体疗法简史]
Med Mal Infect. 2008 Aug;38(8):415-20. doi: 10.1016/j.medmal.2008.06.016. Epub 2008 Aug 9.
8
Phage-Mediated Gene Therapy.噬菌体介导的基因治疗
Curr Gene Ther. 2017;17(2):120-126. doi: 10.2174/1566523217666170510151940.
9
A CRISPR-Cas9-Based Toolkit for Fast and Precise In Vivo Genetic Engineering of Phages.基于 CRISPR-Cas9 的噬菌体体内基因快速精准工程工具包
Viruses. 2018 May 4;10(5):241. doi: 10.3390/v10050241.
10
JD419, a Phage With a Unique Morphology and Broad Host Range.JD419，一种具有独特形态和广泛宿主范围的噬菌体。
Front Microbiol. 2021 Apr 22;12:602902. doi: 10.3389/fmicb.2021.602902. eCollection 2021.
引用本文的文献
1
Deep learning-guided structural analysis of a novel bacteriophage KPP105 against multidrug-resistant .针对多重耐药菌的新型噬菌体KPP105的深度学习引导的结构分析
Comput Struct Biotechnol J. 2025 May 1;27:1827-1837. doi: 10.1016/j.csbj.2025.04.032. eCollection 2025.
2
Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects.噬菌体治疗人类、动物和植物中的多重耐药细菌感染：现状与未来前景。
Infect Med (Beijing). 2025 Feb 5;4(1):100168. doi: 10.1016/j.imj.2025.100168. eCollection 2025 Mar.
3
Therapeutic potential of a newly isolated bacteriophage against multi-drug resistant Enterococcus faecalis infections: in vitro and in vivo characterization.一种新分离的噬菌体对耐多药粪肠球菌感染的治疗潜力：体外和体内特性研究
BMC Microbiol. 2025 Feb 20;25(1):80. doi: 10.1186/s12866-025-03785-z.
4
Isolation and preliminary characterization of a novel bacteriophage vB_KquU_φKuK6 that infects the multidrug-resistant pathogen .一种新型噬菌体vB_KquU_φKuK6的分离及其初步特性鉴定，该噬菌体可感染多重耐药病原体。
Front Microbiol. 2024 Oct 15;15:1472729. doi: 10.3389/fmicb.2024.1472729. eCollection 2024.
5
Invasions of Host-Associated Microbiome Networks.宿主相关微生物群落网络的入侵
Adv Ecol Res. 2017;57:201-281. doi: 10.1016/bs.aecr.2016.11.002.
6
Bacterial diseases in marine fish species: current trends and future prospects in disease management.海洋鱼类细菌性疾病：疾病管理的现状趋势和未来展望。
World J Microbiol Biotechnol. 2023 Sep 25;39(11):317. doi: 10.1007/s11274-023-03755-5.
7
The Lytic Activity of Bacteriophage ZCSE9 against and Its Synergistic Effects with Kanamycin.噬菌体 ZCSE9 对 的裂解活性及其与卡那霉素的协同作用。
Viruses. 2023 Mar 31;15(4):912. doi: 10.3390/v15040912.
8
Isolation of new phage PSKP16.新型噬菌体PSKP16的分离
Iran J Microbiol. 2023 Feb;15(1):62-68. doi: 10.18502/ijm.v15i1.11919.
9
Characterization of Novel Phage PG14 and Its Antibiofilm Efficacy.新型噬菌体 PG14 的特性及其抗生物膜功效。
Microbiol Spectr. 2022 Dec 21;10(6):e0199422. doi: 10.1128/spectrum.01994-22. Epub 2022 Nov 14.
10
Chitosan-Based Microparticle Encapsulated Phage Cocktail in Hydrogel Matrix for the Management of Multidrug Resistant Chronic Wound Infection.基于壳聚糖的微粒包裹噬菌体鸡尾酒制剂在水凝胶基质中用于治疗多重耐药慢性伤口感染
Turk J Pharm Sci. 2022 Apr 29;19(2):187-195. doi: 10.4274/tjps.galenos.2021.72547.
本文引用的文献
1
Comparison of culture and molecular identification of bacteria in chronic wounds.慢性伤口中细菌培养与分子鉴定的比较
Int J Mol Sci. 2012;13(3):2535-2550. doi: 10.3390/ijms13032535. Epub 2012 Feb 23.
2
Bug breakfast in the Bulletin: antimicrobial resistance: moving forward to the past.《简报》中的“错误早餐”：抗菌素耐药性——向过去迈进
N S W Public Health Bull. 2012 Jan-Feb;23(1-2):37. doi: 10.1071/NB11043.
3
Pathogen identification with laser-induced breakdown spectroscopy: the effect of bacterial and biofluid specimen contamination.基于激光诱导击穿光谱技术的病原体鉴定：细菌和生物流体样本污染的影响
Appl Opt. 2012 Mar 1;51(7):B99-107. doi: 10.1364/AO.51.000B99.
4
Phage treatment of human infections.噬菌体对人类感染的治疗。
Bacteriophage. 2011 Mar;1(2):66-85. doi: 10.4161/bact.1.2.15845.
5
Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.单次克林霉素给药导致肠道微生物群的深刻改变，从而使机体持续易患艰难梭菌诱导的结肠炎。
Infect Immun. 2012 Jan;80(1):62-73. doi: 10.1128/IAI.05496-11. Epub 2011 Oct 17.
6
The next generation of bacteriophage therapy.下一代噬菌体疗法。
Curr Opin Microbiol. 2011 Oct;14(5):524-31. doi: 10.1016/j.mib.2011.07.028. Epub 2011 Aug 23.
7
Preserving the lifesaving power of antimicrobial agents.保留抗菌药物的救命功效。
JAMA. 2011 Mar 9;305(10):1027-8. doi: 10.1001/jama.2011.279. Epub 2011 Feb 22.
8
PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response.噬菌体的聚乙二醇化可以增加血液循环时间，减少 T 辅助型 1 免疫反应。
Microb Biotechnol. 2008 May;1(3):247-57. doi: 10.1111/j.1751-7915.2008.00028.x.
9
Bacteriophages as potential new therapeutics to replace or supplement antibiotics.噬菌体作为潜在的新型治疗药物，可以替代或补充抗生素。
Trends Biotechnol. 2010 Dec;28(12):591-5. doi: 10.1016/j.tibtech.2010.08.001. Epub 2010 Aug 31.
10
Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial.用噬菌体混合物治疗犬绿脓假单胞菌中耳炎的局部治疗：一项前后临床试验。
Vet Microbiol. 2010 Dec 15;146(3-4):309-13. doi: 10.1016/j.vetmic.2010.05.014. Epub 2010 May 12.
Zotero 插件